BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 28126460)

  • 1. Laboratory-based and office-based risk scores and charts to predict 10-year risk of cardiovascular disease in 182 countries: a pooled analysis of prospective cohorts and health surveys.
    Ueda P; Woodward M; Lu Y; Hajifathalian K; Al-Wotayan R; Aguilar-Salinas CA; Ahmadvand A; Azizi F; Bentham J; Cifkova R; Di Cesare M; Eriksen L; Farzadfar F; Ferguson TS; Ikeda N; Khalili D; Khang YH; Lanska V; León-Muñoz L; Magliano DJ; Margozzini P; Msyamboza KP; Mutungi G; Oh K; Oum S; Rodríguez-Artalejo F; Rojas-Martinez R; Valdivia G; Wilks R; Shaw JE; Stevens GA; Tolstrup JS; Zhou B; Salomon JA; Ezzati M; Danaei G
    Lancet Diabetes Endocrinol; 2017 Mar; 5(3):196-213. PubMed ID: 28126460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel risk score to predict cardiovascular disease risk in national populations (Globorisk): a pooled analysis of prospective cohorts and health examination surveys.
    Hajifathalian K; Ueda P; Lu Y; Woodward M; Ahmadvand A; Aguilar-Salinas CA; Azizi F; Cifkova R; Di Cesare M; Eriksen L; Farzadfar F; Ikeda N; Khalili D; Khang YH; Lanska V; León-Muñoz L; Magliano D; Msyamboza KP; Oh K; Rodríguez-Artalejo F; Rojas-Martinez R; Shaw JE; Stevens GA; Tolstrup J; Zhou B; Salomon JA; Ezzati M; Danaei G
    Lancet Diabetes Endocrinol; 2015 May; 3(5):339-55. PubMed ID: 25819778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laboratory-based and office-based Globorisk scores to predict 10-year risk of cardiovascular diseases among Iranians: results from the Fasa PERSIAN cohort.
    Jahangiry L; Dehghan A; Farjam M; Aune D; Rezaei F
    BMC Med Res Methodol; 2022 Nov; 22(1):305. PubMed ID: 36435774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Nonblood-Based and Blood-Based Total CV Risk Scores in Global Populations.
    Gaziano TA; Abrahams-Gessel S; Alam S; Alam D; Ali M; Bloomfield G; Carrillo-Larco RM; Dorairaj P; Gutierrez L; Irazola V; Levitt NS; Miranda JJ; Bernabe-Ortiz A; Pandya A; Rubinstein A; Steyn K; Xavier D; Yan LL
    Glob Heart; 2016 Mar; 11(1):37-46.e2. PubMed ID: 27102021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions.
    WHO CVD Risk Chart Working Group
    Lancet Glob Health; 2019 Oct; 7(10):e1332-e1345. PubMed ID: 31488387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative assessment of absolute cardiovascular disease risk characterization from non-laboratory-based risk assessment in South African populations.
    Gaziano TA; Pandya A; Steyn K; Levitt N; Mollentze W; Joubert G; Walsh CM; Motala AA; Kruger A; Schutte AE; Naidoo DP; Prakaschandra DR; Laubscher R
    BMC Med; 2013 Jul; 11():170. PubMed ID: 23880010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Ten-Year Risk Prediction for Cardiovascular Disease for Malaysian Adults Using the Laboratory-Based and Office-Based (Globorisk) Prediction Model.
    Che Nawi CMNH; Omar MA; Keegan T; Yu YP; Musa KI
    Medicina (Kaunas); 2022 May; 58(5):. PubMed ID: 35630073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of laboratory-based and office-based Framingham risk scores to predict 10-year risk of cardiovascular diseases: a population-based study.
    Dehghan A; Ahmadnia Motlagh S; Khezri R; Rezaei F; Aune D
    J Transl Med; 2023 Oct; 21(1):687. PubMed ID: 37789412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular disease risk profile and management practices in 45 low-income and middle-income countries: A cross-sectional study of nationally representative individual-level survey data.
    Peiris D; Ghosh A; Manne-Goehler J; Jaacks LM; Theilmann M; Marcus ME; Zhumadilov Z; Tsabedze L; Supiyev A; Silver BK; Sibai AM; Norov B; Mayige MT; Martins JS; Lunet N; Labadarios D; Jorgensen JMA; Houehanou C; Guwatudde D; Gurung MS; Damasceno A; Aryal KK; Andall-Brereton G; Agoudavi K; McKenzie B; Webster J; Atun R; Bärnighausen T; Vollmer S; Davies JI; Geldsetzer P
    PLoS Med; 2021 Mar; 18(3):e1003485. PubMed ID: 33661979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of statins for the prevention of cardiovascular disease in 41 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data.
    Marcus ME; Manne-Goehler J; Theilmann M; Farzadfar F; Moghaddam SS; Keykhaei M; Hajebi A; Tschida S; Lemp JM; Aryal KK; Dunn M; Houehanou C; Bahendeka S; Rohloff P; Atun R; Bärnighausen TW; Geldsetzer P; Ramirez-Zea M; Chopra V; Heisler M; Davies JI; Huffman MD; Vollmer S; Flood D
    Lancet Glob Health; 2022 Mar; 10(3):e369-e379. PubMed ID: 35180420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of Cardiovascular Disease Mortality in a Middle Eastern Country: Performance of the Globorisk and Score Functions in Four Population-Based Cohort Studies of Iran.
    Fahimfar N; Fotouhi A; Mansournia MA; Malekzadeh R; Sarrafzadegan N; Azizi F; Mansourian M; Sepanlou SG; Emamian MH; Hadaegh F; Roohafza H; Hashemi H; Poustchi H; Pourshams A; Samavat T; Sharafkhah M; Talaei M; Van Klaveren D; Steyerberg EW; Khalili D
    Int J Health Policy Manag; 2022 Feb; 11(2):210-217. PubMed ID: 32668896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic validation of a non-laboratory and a laboratory based cardiovascular disease risk score in multiple regions of the world.
    Joseph P; Yusuf S; Lee SF; Ibrahim Q; Teo K; Rangarajan S; Gupta R; Rosengren A; Lear SA; Avezum A; Lopez-Jaramillo P; Gulec S; Yusufali A; Chifamba J; Lanas F; Kumar R; Mohammadifard N; Mohan V; Mony P; Kruger A; Liu X; Guo B; Zhao W; Yang Y; Pillai R; Diaz R; Krishnapillai A; Iqbal R; Yusuf R; Szuba A; Anand SS;
    Heart; 2018 Apr; 104(7):581-587. PubMed ID: 29066611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agreement Between Cardiovascular Disease Risk Scores in Resource-Limited Settings: Evidence from 5 Peruvian Sites.
    Bazo-Alvarez JC; Quispe R; Peralta F; Poterico JA; Valle GA; Burroughs M; Pillay T; Gilman RH; Checkley W; Malaga G; Smeeth L; Bernabé-Ortiz A; Miranda JJ;
    Crit Pathw Cardiol; 2015 Jun; 14(2):74-80. PubMed ID: 26102017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of total cardiovascular risk using WHO/ISH risk prediction charts in three low and middle income countries in Asia.
    Otgontuya D; Oum S; Buckley BS; Bonita R
    BMC Public Health; 2013 Jun; 13():539. PubMed ID: 23734670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body-mass index and diabetes risk in 57 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data in 685 616 adults.
    Teufel F; Seiglie JA; Geldsetzer P; Theilmann M; Marcus ME; Ebert C; Arboleda WAL; Agoudavi K; Andall-Brereton G; Aryal KK; Bicaba BW; Brian G; Bovet P; Dorobantu M; Gurung MS; Guwatudde D; Houehanou C; Houinato D; Jorgensen JMA; Kagaruki GB; Karki KB; Labadarios D; Martins JS; Mayige MT; McClure RW; Mwangi JK; Mwalim O; Norov B; Crooks S; Farzadfar F; Moghaddam SS; Silver BK; Sturua L; Wesseh CS; Stokes AC; Essien UR; De Neve JW; Atun R; Davies JI; Vollmer S; Bärnighausen TW; Ali MK; Meigs JB; Wexler DJ; Manne-Goehler J
    Lancet; 2021 Jul; 398(10296):238-248. PubMed ID: 34274065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variations between women and men in risk factors, treatments, cardiovascular disease incidence, and death in 27 high-income, middle-income, and low-income countries (PURE): a prospective cohort study.
    Walli-Attaei M; Joseph P; Rosengren A; Chow CK; Rangarajan S; Lear SA; AlHabib KF; Davletov K; Dans A; Lanas F; Yeates K; Poirier P; Teo KK; Bahonar A; Camilo F; Chifamba J; Diaz R; Didkowska JA; Irazola V; Ismail R; Kaur M; Khatib R; Liu X; Mańczuk M; Miranda JJ; Oguz A; Perez-Mayorga M; Szuba A; Tsolekile LP; Prasad Varma R; Yusufali A; Yusuf R; Wei L; Anand SS; Yusuf S
    Lancet; 2020 Jul; 396(10244):97-109. PubMed ID: 32445693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of laboratory-based and non-laboratory-based WHO cardiovascular disease risk charts: a population-based study.
    Rezaei F; Seif M; Gandomkar A; Fattahi MR; Malekzadeh F; Sepanlou SG; Hasanzadeh J
    J Transl Med; 2022 Mar; 20(1):133. PubMed ID: 35296342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of physical activity on mortality and cardiovascular disease in 130 000 people from 17 high-income, middle-income, and low-income countries: the PURE study.
    Lear SA; Hu W; Rangarajan S; Gasevic D; Leong D; Iqbal R; Casanova A; Swaminathan S; Anjana RM; Kumar R; Rosengren A; Wei L; Yang W; Chuangshi W; Huaxing L; Nair S; Diaz R; Swidon H; Gupta R; Mohammadifard N; Lopez-Jaramillo P; Oguz A; Zatonska K; Seron P; Avezum A; Poirier P; Teo K; Yusuf S
    Lancet; 2017 Dec; 390(10113):2643-2654. PubMed ID: 28943267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recalibration of the SCORE risk chart for the Russian population.
    Jdanov DA; Deev AD; Jasilionis D; Shalnova SA; Shkolnikova MA; Shkolnikov VM
    Eur J Epidemiol; 2014 Sep; 29(9):621-8. PubMed ID: 25179794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment.
    Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration
    Lancet Diabetes Endocrinol; 2014 Aug; 2(8):634-47. PubMed ID: 24842598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.